Alternatively, ABT-737 has been reported to potentiate the TRAIL-induced apoptosis of human pancreatic cancer cells by conformationally changing Bax and disrupting the binding of Bak with Bcl-xL [43]. This evidence concerns the gene TNFSF10 and familial pancreatic carcinoma.